Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma

D. Cella*, A. G. Bushmakin, J. C. Cappelleri, C. Charbonneau, M. D. Michaelson, R. J. Motzer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences